Clindesse

Product NDC: 45802-042
11-digit product format: 458020042
Labeler code: 45802
Product ID: 45802-042_ab0a6fe2-5ee0-408c-9e1d-30ce29344d16
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: clindamycin phosphate
Dosage form: CREAM
Route: VAGINAL
Labeler: Padagis Israel Pharmaceuticals Ltd
Application: NDA050793
Marketing category: NDA
Marketing start: 2015-07-03
Substance: CLINDAMYCIN PHOSPHATE
Active strength: 100 mg/5g
Pharmacologic classes: Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N050793-001	CLINDESSE	CLINDAMYCIN PHOSPHATE	EQ 2% BASE	CREAM / VAGINAL		RLD, RS	2004-11-30

Orange Book patents#

Current patent rows page 1 of 1 · 1 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N050793-001	CLINDESSE	EQ 2% BASE	CREAM / VAGINAL	RLD, RS	2004-11-30	`e64feba35796…`

Observed Orange Book patent history#

Patent history page 1 of 2 · 66 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-08-18 06:07:40	2026-07	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N050793-001	6899890	2023-04-27	U-137	Drug product		`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N050793-001	6899890	2023-04-27	U-137	Drug product		`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N050793-001	6899890	2023-04-27	U-137	Drug product		`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N050793-001	6899890	2023-04-27	U-137	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N050793-001	6899890	2023-04-27	U-137	Drug product		`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N050793-001	6899890	2023-04-27	U-137	Drug product		`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N050793-001	6899890	2023-04-27	U-137	Drug product		`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N050793-001	6899890	2023-04-27	U-137	Drug product		`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N050793-001	6899890	2023-04-27	U-137	Drug product		`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N050793-001	6899890	2023-04-27	U-137	Drug product		`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N050793-001	6899890	2023-04-27	U-137	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N050793-001	6899890	2023-04-27	U-137	Drug product		`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N050793-001	9789057	2026-12-02	U-137	Drug product	2018-01-09	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N050793-001	6899890	2023-04-27	U-137	Drug product		`ea99ee380514…`

Additional Listing Data#

Finished product: Yes
Brand name base: Clindesse
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CLINDAMYCIN PHOSPHATE	100 mg/5g

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
EH6D7113I8	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
309337	Internal RxNorm lookup
602427	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
fe8bb204-f173-44fe-803b-b08f2ec5aa31	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
a46239a7-5963-4008-8cbb-6b9000f497eb	Product name	1	20250721
1426d8f8-b7d5-4053-8554-613df00c0d86	Product name	2	20250616
b382b4e1-6b48-45f6-bffc-e61b00b0ce19	Product name	3	20250317
d8f81258-db12-0761-46cc-8ff6e62e9302	Product name	4	20240422
b7b2fa42-1c77-d724-81f0-87da60a77e79	Product name	3	20240320
b27c7c65-51f2-a62f-e0e6-a26b3a0f8eb0	Product name	3	20230425
e3af9708-3004-7392-4046-5311eaa8bab5	Product name	3	20221128
ffb4bacf-f636-0f7d-0b0d-7a4b151243e3	Product name	9	20220928
b72227d6-0388-43bd-995b-b762d2754cd5	Product name	1	20220706
a92d22e0-3af4-f301-bc88-27ff030b0070	Product name	2	20220316
4a7d44fe-774d-404b-aad0-8a90fe78375a	Product name	4	20211025
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27b	Product name	3	20200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992	Product name	4	20190619
5ce6ce33-4f2b-3ce0-757d-e520013280cf	Product name	5	20180719
b92a26f1-6926-4817-be73-e26ab4c2146f	Product name	1	20170602
028d6c95-5012-6976-2075-dee0ae6fefe2	Product name	1	20140508
468b2c08-8adb-8d0f-8257-c6515a061424	Product name	1	20140508
8959fb29-d86f-c521-666a-b4cb22233594	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
45802-042-01	Clindesse	5 g in 1 APPLICATOR	CREAM	5	12
45802-042-01	Clindesse	1 in 1 CARTON	CREAM	1	12
45802-042-02	Clindesse	1 in 1 CARTON	CREAM	1	12
45802-042-02	Clindesse	5 g in 1 APPLICATOR	CREAM	5	12

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
45802-042-01	GM - Gram	45802-042	83e90ef2-4fea-4214-b68e-1d192d02d694	1	2015-07-20

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CLINDAMYCIN PHOSPHATE	ACTIVE INGREDIENT	EH6D7113I8	CLINDESSE (CLINDAMYCIN PHOSPHATE) CREAM [PERRIGO NEW YORK INC]	3
CLINDAMYCIN	ACTIVE MOIETY	3U02EL437C	CLINDESSE (CLINDAMYCIN PHOSPHATE) CREAM [PERRIGO NEW YORK INC]	3
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	CLINDESSE (CLINDAMYCIN PHOSPHATE) CREAM [PERRIGO NEW YORK INC]	3
GLYCERYL ISOSTEARATE	INACTIVE INGREDIENT	HYE7O27HAO	CLINDESSE (CLINDAMYCIN PHOSPHATE) CREAM [PERRIGO NEW YORK INC]	3
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	CLINDESSE (CLINDAMYCIN PHOSPHATE) CREAM [PERRIGO NEW YORK INC]	3
MICROCRYSTALLINE WAX	INACTIVE INGREDIENT	XOF597Q3KY	CLINDESSE (CLINDAMYCIN PHOSPHATE) CREAM [PERRIGO NEW YORK INC]	3
MINERAL OIL	INACTIVE INGREDIENT	T5L8T28FGP	CLINDESSE (CLINDAMYCIN PHOSPHATE) CREAM [PERRIGO NEW YORK INC]	3
POLYGLYCERYL-3 OLEATE	INACTIVE INGREDIENT	XRQ165498B	CLINDESSE (CLINDAMYCIN PHOSPHATE) CREAM [PERRIGO NEW YORK INC]	3
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	CLINDESSE (CLINDAMYCIN PHOSPHATE) CREAM [PERRIGO NEW YORK INC]	3
SORBITOL	INACTIVE INGREDIENT	506T60A25R	CLINDESSE (CLINDAMYCIN PHOSPHATE) CREAM [PERRIGO NEW YORK INC]	3
WATER	INACTIVE INGREDIENT	059QF0KO0R	CLINDESSE (CLINDAMYCIN PHOSPHATE) CREAM [PERRIGO NEW YORK INC]	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
45802-042	CLINDESSE (CLINDAMYCIN PHOSPHATE) CREAM [PADAGIS ISRAEL PHARMACEUTICALS LTD]	11	Current NDC, Legacy NDC, 4 package rows	20250207_fe8bb204-f173-44fe-803b-b08f2ec5aa31.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Clindesse	CLINDAMYCIN PHOSPHATE	Padagis Israel Pharmaceuticals Ltd	fe8bb204-f173-44fe-803b-b08f2ec5aa31	2025-01-30	Warnings, Adverse reactions	Exact identifier application applno (NDA): 050793 application number: NDA050793 ndc (product): 45802-042

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
EH6D7113I8	CLINDAMYCIN PHOSPHATE	24729-96-2	CLINDAMYCIN PHOSPHATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
309337	clindamycin phosphate 2 % Vaginal Cream	PSN	fe8bb204-f173-44fe-803b-b08f2ec5aa31	12
602427	Clindesse 2 % Vaginal Cream	PSN	fe8bb204-f173-44fe-803b-b08f2ec5aa31	12
602427	clindamycin 20 MG/ML Vaginal Cream [Clindesse]	SBD	fe8bb204-f173-44fe-803b-b08f2ec5aa31	12
309337	clindamycin 20 MG/ML Vaginal Cream	SCD	fe8bb204-f173-44fe-803b-b08f2ec5aa31	12
309337	clindamycin (as clindamycin phosphate) 2 % Vaginal Cream	SY	fe8bb204-f173-44fe-803b-b08f2ec5aa31	12
309337	clindamycin 2 % Vaginal Cream	SY	fe8bb204-f173-44fe-803b-b08f2ec5aa31	12
602427	Clindesse (as clindamycin phosphate) 2 % Vaginal Cream	SY	fe8bb204-f173-44fe-803b-b08f2ec5aa31	12
602427	Clindesse 2 % Vaginal Cream	SY	fe8bb204-f173-44fe-803b-b08f2ec5aa31	12
602427	Clindesse 20 MG/ML Vaginal Cream	SY	fe8bb204-f173-44fe-803b-b08f2ec5aa31	12

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
45802-042-01	45802004201	1 APPLICATOR in 1 CARTON (45802-042-01) / 5 g in 1 APPLICATOR	1 applicator	2015-07-03	0000-00-00	No	No	Current
45802-042-02	45802004202	1 APPLICATOR in 1 CARTON (45802-042-02) / 5 g in 1 APPLICATOR	1 applicator	2015-07-03	0000-00-00	Yes	No	Current